Ardent Health Partners (ARDT) Projected to Post Earnings on Wednesday

Ardent Health Partners (NYSE:ARDT - Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Wednesday, February 5th. Analysts expect Ardent Health Partners to post earnings of $0.45 per share for the quarter. Ardent Health Partners has set its FY 2024 guidance at 1.230-1.370 EPS.Parties that wish to listen to the company's conference call can do so using this link.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last announced its earnings results on Wednesday, November 6th. The company reported $0.19 earnings per share for the quarter, missing analysts' consensus estimates of $0.29 by ($0.10). The company had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.46 billion. On average, analysts expect Ardent Health Partners to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Ardent Health Partners Price Performance

ARDT stock traded down $0.12 during midday trading on Wednesday, reaching $14.68. The company had a trading volume of 159,789 shares, compared to its average volume of 390,127. The company's 50-day moving average is $15.90. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. Ardent Health Partners has a 1 year low of $13.63 and a 1 year high of $20.72.

Analysts Set New Price Targets

A number of research firms recently commented on ARDT. Leerink Partners increased their target price on Ardent Health Partners from $23.00 to $25.00 and gave the company an "outperform" rating in a research note on Tuesday, November 12th. Bank of America lowered Ardent Health Partners from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $22.00 to $19.00 in a research report on Wednesday, November 6th. JPMorgan Chase & Co. restated a "neutral" rating and issued a $20.00 target price on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Morgan Stanley reduced their price objective on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 21st. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and issued a $23.00 target price on shares of Ardent Health Partners in a research note on Thursday, November 14th. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $21.55.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.